Tibor Szarvas
18PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Jan 16, 2025
Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy.Csilla Olah, Oleksandr Shmorhun, Gilbert Georg Klamminger
|Nov 14, 2024
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers.Csilla Olah, Fabian Mairinger, Michael Wessolly
|Jun 07, 2024
Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†.Tibor Szarvas, Henning Reis
|Aug 26, 2023
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.Anita Csizmarik, Nikolett Nagy, Dávid Keresztes
|Dec 12, 2022
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.Tamás Fazekas, Ádám D Széles, Brigitta Teutsch
|Jun 11, 2022
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.Anita Csizmarik, Dávid Keresztes, Nikolett Nagy
Pageof 3
Frequent Collaborators
6 joint publications
Henning Reis
3 joint publications
Csilla Olah
2 joint publications
Anita Csizmarik
2 joint publications
Ilona Tornyi
2 joint publications
Martin Puhr
2 joint publications
Kathrin Witzke
1 joint publications
Lukas Püllen
1 joint publications
Melinda Varadi
1 joint publications
Nadina Ortiz-Brüchle
1 joint publications
Stefan Garczyk
